Received May 28, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | JZ9NF | IM / RA |
tingling finger; numbness in two fingers; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of tingling of extremity in a 64-year-old female patient who received Herpes zoster (Shingrix) suspension for injection in pre-filled syringe (batch number JZ9NF with expiry date 08-JUL-2028) for prophylaxis. On 22-MAY-2026, the patient received the 1st dose of Shingrix (intramuscular, right deltoid). On 22-MAY-2026, immediately after receiving Shingrix, the patient experienced tingling of extremity (Verbatim: tingling finger) and numbness in fingers (Verbatim: numbness in two fingers). The outcome of the tingling of extremity and numbness in fingers were unknown. It was unknown if the reporter considered the tingling of extremity and numbness in fingers to be related to Shingrix and Shingrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-MAY-2026 The reporter did not know which hand or which fingers these adverse events were associated with. The reporter advised the patient to go to a physician to be seen. No further information was provided. The reporter reported all that was provided about these adverse events.